NEW YORK (GenomeWeb) – Claritas Genomics announced today that it has received New York State Department of Health approval to start offering its Clinical Exome and Pediatric Neurology Region of Interest diagnostic tests in New York.

The company — which was created by Boston Children's Hospital and Cincinnati Children's Hospital in partnership with Cerner, Wuxi NextCode Genomics, and Thermo Fisher Scientific — offers the Clinical Exome test for people with complex, multi-systemic symptoms, or conditions with genetic and phenotypic heterogeneity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.